ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Medplus Health Services (MEDPLUS.NSE)
Medplus Health Services share price today, ATLAS forecast and fair value
Healthcare · Pharmaceutical Retailers · National Stock Exchange of India · India
₹608.15▲ +2.18%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
52%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Medplus Health Services in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Medplus Health Services
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Medplus Health Services a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹585.74 and ₹635.81; in 9 out of 10, between ₹544.66 and ₹683.77. Estimated annual volatility is 22%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹72.0B
- Market cap (USD)
- $760M
- P/E ratio
- 34.0
- 52-week high
- ₹1,022
- 52-week low
- ₹576.30
- Revenue (12 months)
- ₹72.3B
- Operating margin
- 2.9%
- Net margin
- 2.9%
- Beta
- 0.46
What this means
ATLAS does not publish a fair value for MEDPLUS.NSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks MEDPLUS.NSE has traded between ₹576.30 and ₹1,022. Today it is 40.5% below that high and 6% above its low.
On the business: net margin is 2.9%; it trades at 34.0 times earnings.
Its beta is 0.46: it tends to move less than the market.
About the company
Medplus Health Services Ltd. operates as a dominant player in India’s pharmacy retail and healthcare services sector.
Want to see everything about Medplus Health Services?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Medplus Health Services do?
Medplus Health Services Ltd. operates as a dominant player in India’s pharmacy retail and healthcare services sector.
What is the chance MEDPLUS.NSE goes up next month?
52%: close to a coin flip. In half of the simulated outcomes, MEDPLUS.NSE ends the month between ₹585.74 and ₹635.81.
How big is Medplus Health Services and what is its P/E ratio?
Medplus Health Services's market capitalization is ₹72.0B. Its price-to-earnings (P/E) ratio is 34.0: you pay ₹34.0 for each ₹1.00 of yearly earnings.
How volatile is MEDPLUS.NSE?
ATLAS estimates annual volatility at 22%. In a typical month, half of the outcomes end between ₹585.74 and ₹635.81.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer